• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同抗血栓治疗方案对心肌梗死后血小板聚集的影响。

The effect of different antithrombotic regimens on platelet aggregation after myocardial infarction.

作者信息

Hurlen M, Seljeflot I, Arnesen H

机构信息

Department of Cardiology, Ullevål University Hospital, Oslo, Norway.

出版信息

Scand Cardiovasc J. 1998;32(4):233-7. doi: 10.1080/14017439850140021.

DOI:10.1080/14017439850140021
PMID:9802142
Abstract

Platelet aggregate ratio (PAR) was measured according to the method of Wu & Hoak in 143 patients after acute myocardial infarction (AMI) and in 54 controls. A PAR < 1 expresses the presence of platelet aggregates. The patients were randomized to aspirin 160 mg/d, or warfarin, or aspirin 75 mg/d + warfarin. In patients on aspirin, PAR was measured 24 h after aspirin intake, and in 76 patients also 2 h after aspirin. The median PAR in patients on warfarin was 0.85, on warfarin + aspirin 0.91 and on aspirin alone 0.94, all significantly lower than the median PAR of 0.97 in the controls. In 14 patients on aspirin the PARs were below a cut-off point of 0.82 (secondary aspirin non-responders). PAR increase significantly 2 h after aspirin intake. In two patients, however, PAR remained low (primary aspirin non-responders). It is concluded that some patients do not seem to respond to aspirin, the clinical implication of which has yet to be determined.

摘要

采用Wu和Hoak的方法,对143例急性心肌梗死(AMI)患者和54例对照者测定血小板聚集率(PAR)。PAR<1表示存在血小板聚集。患者被随机分为服用160mg/d阿司匹林组、华法林组或75mg/d阿司匹林+华法林组。服用阿司匹林的患者,在服用阿司匹林24小时后测定PAR,76例患者还在服用阿司匹林2小时后测定。服用华法林患者的PAR中位数为0.85,服用华法林+阿司匹林患者为0.91,单独服用阿司匹林患者为0.94,均显著低于对照组的PAR中位数0.97。14例服用阿司匹林的患者PAR低于0.82的临界点(继发性阿司匹林无反应者)。服用阿司匹林2小时后PAR显著升高。然而,有2例患者PAR仍较低(原发性阿司匹林无反应者)。得出的结论是,一些患者似乎对阿司匹林无反应,其临床意义尚待确定。

相似文献

1
The effect of different antithrombotic regimens on platelet aggregation after myocardial infarction.不同抗血栓治疗方案对心肌梗死后血小板聚集的影响。
Scand Cardiovasc J. 1998;32(4):233-7. doi: 10.1080/14017439850140021.
2
Effect of fixed low-dose warfarin added to aspirin in the long term after acute myocardial infarction; the LoWASA Study.急性心肌梗死后长期添加低剂量固定华法林至阿司匹林的效果;LoWASA研究
Eur Heart J. 2004 Feb;25(3):232-9. doi: 10.1016/j.ehj.2003.10.026.
3
Increased platelet aggregability during exercise in patients with previous myocardial infarction. Lack of inhibition by aspirin.
Thromb Res. 2000 Sep 1;99(5):487-94. doi: 10.1016/s0049-3848(00)00277-2.
4
[Secondary prevention after acute myocardial infarction: aspirin, warfarin or both?].[急性心肌梗死后的二级预防:阿司匹林、华法林还是两者联用?]
Tidsskr Nor Laegeforen. 2003 Jun 26;123(13-14):1838-40.
5
Less benefit from warfarin in diabetics after myocardial infarction?糖尿病患者心肌梗死后服用华法林获益较少?
Cardiology. 2008;111(3):161-6. doi: 10.1159/000121598. Epub 2008 Apr 25.
6
Long-term oral anticoagulant therapy in patients with unstable angina or suspected non-Q-wave myocardial infarction: organization to assess strategies for ischemic syndromes (OASIS) pilot study results.不稳定型心绞痛或疑似非Q波心肌梗死患者的长期口服抗凝治疗:评估缺血综合征策略组织(OASIS)初步研究结果
Circulation. 1998 Sep 15;98(11):1064-70. doi: 10.1161/01.cir.98.11.1064.
7
Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease.采用血小板功能分析仪(PFA-100)检测冠心病患者的阿司匹林抵抗情况。
Thromb Res. 2002 Oct 1;108(1):37-42. doi: 10.1016/s0049-3848(02)00405-x.
8
Progression of the culprit lesion in unstable coronary artery disease with warfarin and aspirin versus aspirin alone: preliminary study.华法林与阿司匹林联用对比单用阿司匹林治疗不稳定型冠状动脉疾病时罪犯病变的进展:初步研究
J Am Coll Cardiol. 1997 Aug;30(2):364-9. doi: 10.1016/s0735-1097(97)00153-8.
9
Atrial fibrillation and acute myocardial infarction: antithrombotic therapy and outcomes.心房颤动和急性心肌梗死:抗血栓治疗与结局。
Am J Med. 2012 Sep;125(9):897-905. doi: 10.1016/j.amjmed.2012.04.006. Epub 2012 Jul 13.
10
A prospective randomized trial of aspirin-clopidogrel combination therapy and dose-adjusted warfarin on indices of thrombogenesis and platelet activation in atrial fibrillation.阿司匹林-氯吡格雷联合治疗与剂量调整华法林对心房颤动血栓形成和血小板活化指标影响的前瞻性随机试验
J Am Coll Cardiol. 2002 Aug 7;40(3):484-90. doi: 10.1016/s0735-1097(02)01984-8.

引用本文的文献

1
Aspirin prophylaxis for the prevention of thrombosis: expectations and limitations.用于预防血栓形成的阿司匹林预防:期望与局限性。
Thrombosis. 2012;2012:104707. doi: 10.1155/2012/104707. Epub 2012 Feb 7.
2
Antiplatelet resistance with aspirin and clopidogrel: is it real and does it matter?阿司匹林和氯吡格雷引起的抗血小板抵抗:它真的存在吗?它重要吗?
Curr Cardiol Rep. 2006 Jul;8(4):301-6. doi: 10.1007/s11886-006-0063-5.